A case of neuromyotonia in Behçet disease during TNF-α antagonist therapy

Neurol Sci. 2014 Oct;35(10):1637-9. doi: 10.1007/s10072-014-1820-7. Epub 2014 May 21.

Authors

Marco Belluzzo¹, Massimo Dozzo, Erika Pigatto, Franco Schiavon, Fabrizio Monti

Affiliation

¹ Neurology Unit, Department of Medical, Surgical and Health Sciences, Azienda Ospedaliero-universitaria Ospedali Riuniti, University of Trieste, Strada di Fiume, 447, 34100, Trieste, Italy, marco.belluzzo@hotmail.com.

PMID: 24844789
DOI: 10.1007/s10072-014-1820-7

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antibodies, Monoclonal / adverse effects
Behcet Syndrome / complications*
Behcet Syndrome / drug therapy*
Humans
Infliximab
Isaacs Syndrome / complications*
Isaacs Syndrome / diagnosis*
Male
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Antibodies, Monoclonal
Tumor Necrosis Factor-alpha
golimumab
Infliximab